One thing CU6 could have done better is explaining this in layman's terms. Australian biotech investors are not very sophisticated (in general) and they need results explained clearly using language that can be understood by non-experts.
Research/Valuation, page-193
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.75 |
Change
0.150(3.26%) |
Mkt cap ! $1.477B | |||
| Open | High | Low | Value | Volume |
| $4.68 | $4.95 | $4.60 | $6.215M | 1.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1808 | $4.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.75 | 5518 | 8 |
View Market Depth
| Last trade - 13.48pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.75 |
Change
0.150 ( 3.97 %) |
||||
| Open | High | Low | Volume | ||
| $4.67 | $4.95 | $4.60 | 93134 | ||
| Last updated 14.06pm 30/05/2024 ? | |||||
| CU6 (ASX) Chart |